MONTREAL, Oct. 1, 2024 /CNW/ - Valeo Pharma Inc. (TSX: VPH) (FSE: VP2), a Canadian pharmaceutical company, announced today that the Québec Superior Court (Commercial Division) (the "Court") has issued an initial order (the "Initial Order") granting the Company and its subsidiaries VPI Pharmaceuticals Inc. / VPI Pharmaceutiques Inc. and Valeo Pharma Corp. (collectively, the "Company" or "Valeo") protection under the Companies' Creditors Arrangement Act (R.S.C., 1985, c. C-36) (the "CCAA").
Read more at newswire.cahello world
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
